Evidence map›Paper›PMID 21473764›Full record

Trial reportBMC pulmonary medicine2011

Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial.

Georgina Braganza, Rekha Chaudhuri, Charles McSharry, Christopher J Weir, Iona Donnelly, Lisa Jolly, Jane Lafferty, Suzanne M Lloyd, Mark Spears, Frances Mair and 1 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC pulmonary medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00463827 phase2completednot on this map

Effect of Statins on Asthma Control and Airway Inflammation in Smokers With Asthma: a Randomised Controlled Double-blind Parallel Group Study

TypeinterventionalSponsorNHS Greater Clyde and GlasgowRan2007 to 2009Enrolled71ConditionsAsthma, COPD, SmokingArmsAtorvastatin, atorvastatin, matched placebo
NCT03511482 nawithdrawnnot on this mapstarted 2019, after this paper: background citation

An Open Feasibility Study to Investigate the Impact of A Digitally Delivered Asthma Service for Patients in Primary Care (IDEAL-001: Integrated Digitally EnhAnced Care for Long-term Conditions-001

TypeinterventionalSponsormy mhealth LtdRan2019 to 2021Enrolled0ConditionsAsthmaArmsmyAsthma Application, Lloyds Pharmacy Online Doctor
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Statins for asthma.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Trial
  4. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Article
  7. Management of the pediatric patient with asthma and obesity.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024
    Review
  8. Sterols and immune mechanisms in asthma.The Journal of allergy and clinical immunology · 2023
    Review
  9. Sterols in asthma.Trends in immunology · 2022
    Review
  10. Article
  11. The potential of Atorvastatin for chronic lung diseases therapy.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Review
  12. Innovations in asthma therapy: is there a role for inhaled statins?Expert review of respiratory medicine · 2018
    Review
  13. Article
  14. Review
  15. Eosinophilic and Noneosinophilic Asthma.American journal of respiratory and critical care medicine · 2018
    Review
  16. Article
  17. Novel approaches to the management of noneosinophilic asthma.Therapeutic advances in respiratory disease · 2016
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Georgina BraganzaRespiratory Medicine, Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.
Rekha Chaudhuri
Charles McSharry
Christopher J Weir
Iona Donnelly
Lisa Jolly
Jane Lafferty
Suzanne M Lloyd
Mark Spears
Frances Mair
Neil C Thomson
University of Glasgow · GBUniversity of Edinburgh · GB

Funding

Medical Research Council G0501955Medical Research Council G0800803
6 · The paper itself

Abstract

backgroundThe immune modulating properties of statins may benefit smokers with asthma. We tested the hypothesis that short-term treatment with atorvastatin improves lung function or indices of asthma control in smokers with asthma.

methodsSeventy one smokers with mild to moderate asthma were recruited to a randomized double-blind parallel group trial comparing treatment with atorvastatin (40 mg per day) versus placebo for 4 weeks. After 4 weeks treatment inhaled beclometasone (400 μg per day) was added to both treatment arms for a further 4 weeks. The primary outcome was morning peak expiratory flow after 4 weeks treatment. Secondary outcome measures included indices of asthma control and airway inflammation.

resultsAt 4 weeks, there was no improvement in the atorvastatin group compared to the placebo group in morning peak expiratory flow [-10.67 L/min, 95% CI -38.70 to 17.37, p = 0.449], but there was an improvement with atorvastatin in asthma quality of life score [0.52, 95% CI 0.17 to 0.87 p = 0.005]. There was no significant improvement with atorvastatin and inhaled beclometasone compared to inhaled beclometasone alone in outcome measures at 8 weeks.

conclusionsShort-term treatment with atorvastatin does not alter lung function but may improve asthma quality of life in smokers with mild to moderate asthma.

trial registrationClinicaltrials.gov identifier: NCT00463827.

Indexed as

SmokingAdultAnti-Asthmatic AgentsAnti-Inflammatory Agents, Non-SteroidalAsthmaAtorvastatinBeclomethasoneDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationFemaleForced Expiratory VolumeHeptanoic AcidsHumansMalePeak Expiratory Flow RateAnti-Asthmatic AgentsAnti-Inflammatory Agents, Non-SteroidalAtorvastatinBeclomethasoneHeptanoic AcidsPyrroles

Identifiers

PMID21473764
PMCPMC3087704
OpenAlexW1998430608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.